清禾

$SpaceX(SPCX.US)

The downward momentum is quite strong, waiting for the prince's difficult time &

$INSILICO(03696.HK)

The recent surge over the past couple of days is due to several factors: Rentosertib entering Phase III clinical trials, with the core drug moving into late-stage validation; a positive profit forecast for mid-2026, indicating the business model is starting to generate revenue and profits; and consecutive collaborations with companies like Lilly, SK, and Takeda, which validate the platform's value among major pharmaceutical firms. After the lock-up pressure, the stock price didn't collapse but was instead absorbed by capital, restoring market confidence.

Revaluing from an "AI drug discovery concept stock" to an "AI drug discovery platform biotech." 😃

$INSILICO(03696.HK) Let's keep going~

$INSILICO(03696.HK)

Phase 3, earnings report that exceeded expectations, the release of pressure after the lock-up period ended, the overlap of three positive factors, it's bound to take off for a while, buckle up and let's go! 😂

$INSILICO(03696.HK)

It's up to you now😃

$INSILICO(03696.HK) is a very excellent stock, worth holding for the long term. As AI develops to a certain extent, people start to pay attention to immortality and reverse aging, and Insilico Medicine is a player in this field. Waiting for it to bloom, finally got a relatively satisfactory position yesterday!

$SpaceX(SPCX.US) Start a small observation position, wait and see, and gradually buy in batches!

$Recursion Pharmaceuticals(RXRX.US)

NVIDIA's exit has not affected the company's fundamentals. If the goal is to hold for 1-3 years or more, there's no need to worry. NVIDIA previously exited the robot delivery company SERV, and that company's stock actually surged several times. Focus more on researching data and fundamentals; don't let emotions make you panic! 😃

$Recursion Pharmaceuticals(RXRX.US)

No matter how the wind and clouds change, as long as you don't leverage, just sit back and enjoy the maple forest at dusk!

$Tesla(TSLA.US)

Which institution is buying😃

$Miniso(MNSO.US)

Add some MINISO, optimistic about Chinese IP going global, optimistic about Lao Ye, time as a companion, ten-bagger, mark my words.

$Recursion Pharmaceuticals(RXRX.US)

The expectation of an interest rate cut is getting stronger, you're about to stand up! 😃

$Recursion Pharmaceuticals(RXRX.US) I placed some June calls before going to bed and unexpectedly they got executed, not bad not bad,

$INSILICO(03696.HK)

Still being opportunistic, didn't enter at a good opportunity point, waiting for a chance, hope to be given this opportunity!

$XIAOMI-W(01810.HK)

Overestimated Lei Jun's reflective spirit, still explaining and educating in an old-fashioned tone, guiding consumers, goodbye, not just the stock, but also some of your product lines!

AI medicine has reached the final mile of verification, and there must be a surprise in 2026, which is also a reward for patience$Recursion Pharmaceuticals(RXRX.US)😊

$Recursion Pharmaceuticals(RXRX.US)

Looks like it's about to take off, adding a bit more 😎

$Recursion Pharmaceuticals(RXRX.US)

Holding long calls with clear logic

$Recursion Pharmaceuticals(RXRX.US)

Held for almost a year, ups and downs, but based on the principle of understanding, the cost has been reduced to a very low level, the margin of safety is sufficient, just waiting for the "empirical" logic loop of AI pharmaceutical R&D to be validated, be a friend of time!

$Recursion Pharmaceuticals(RXRX.US)

The stock of Recursion (RxRx) has been held for a while, from initially speculating following NVIDIA's rhythm to now researching its company, leadership, management, products, including the business model. It's a great target. If you're also interested and planning to hold long-term, let's chat!

$Tesla(TSLA.US)

Tesla FSD iterations:

FSD1-8 (2016-2020): Expanded basic Autopilot features, primarily rule-based logic

FSD9-11 (2021-2023): Abandoned radar for pure vision approach, significantly increased neural network usage

FSD12 (2024.3): Major architectural shift to end-to-end system replacing hard-coded rules, fully AI-driven

FSD13 (2024.11): Dramatically increased parameter scale, integrated highway and urban models

FSD14 (2025.10): 10x parameter increase, largest upgrade since v12

At this iteration pace, who knows how FSD19 will perform in 2030? 🤣

$Recursion Pharmaceuticals(RXRX.US)

So strong, keep going, bro

$Recursion Pharmaceuticals(RXRX.US)

REC—617's recent progress is about to be announced, let's watch the storm rise!

$Recursion Pharmaceuticals(RXRX.US)

You're acting a bit strange today, is there any good news?